Drug Target Review2025-02-27T09:00:18
Researchers have identified a small gene, SCN10a-short, that could enable gene therapy to treat malignant cardiac arrhythmias. This discovery offers the potential for a one-time treatment, reducing the reliance on lifelong medication and invasive procedures.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2026-08-20T08:43:00
Author Dr Daniel Tillett
2026-08-10T08:58:00
Author Abhishek Jha
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2023-06-29T09:19:53
Sponsored by BMG Labtech GmbH
Site powered by Webvision Cloud